New graphene-containing pharmaceutical formulations for infrared lamps-based phototherapy of skin cancer: In vitro validation and ex-vivo human skin permeation

Filipa A.L.S. Silva,Soraia Pinto,Susana G. Santos,Fernão D. Magalhães,Bruno Sarmento,Artur M. Pinto
DOI: https://doi.org/10.1016/j.nano.2024.102734
IF: 6.458
2024-01-31
Nanomedicine Nanotechnology Biology and Medicine
Abstract:Basal cell carcinoma (BCC) is the most common form of human cancer, and treatment usually involves surgery, with alternative strategies being need. We propose the use of carbopol hydrogels (HG) for topical administration of nanographene oxide (GOn) and partially-reduced nanographene oxide (p-rGOn) for photothermal therapy (PTT) of BCC. GOn and p-rGOn into the HG present lateral sizes ~200 nm, being stable for 8 months. After 20 min irradiation with an infrared (IR) photothermal therapy lamp source (15.70 mW cm −2 ), GOn-HG increased temperature to 44.7 °C, while p-rGOn-HG reached 47.0 °C. Human skin fibroblasts (HFF-1) cultured with both hydrogels (250 μg mL −1 ) maintain their morphology and viability. After 20 min IR irradiation, p-rGOn HG (250 μg mL −1 ) completely eradicate skin cancer cells (A-431). Ex vivo human skin permeability tests show that the materials can successfully achieve therapeutic concentrations (250 μg mL −1 ) inside the skin, in 2.0 h for GO HG or 0.5 h for p-rGOn HG.
medicine, research & experimental,nanoscience & nanotechnology
What problem does this paper attempt to address?